Free Trial

Titan Pharmaceuticals (TTNP) Competitors

Titan Pharmaceuticals logo
$4.07 -1.06 (-20.66%)
Closing price 03:59 PM Eastern
Extended Trading
$4.16 +0.09 (+2.09%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TTNP vs. CARM, CTXR, ATHA, CASI, PRPH, ALLR, MTEX, EQ, ERNA, and PMN

Should you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include Carisma Therapeutics (CARM), Citius Pharmaceuticals (CTXR), Athira Pharma (ATHA), CASI Pharmaceuticals (CASI), ProPhase Labs (PRPH), Allarity Therapeutics (ALLR), Mannatech (MTEX), Equillium (EQ), Ernexa Therapeutics (ERNA), and Promis Neurosciences (PMN). These companies are all part of the "pharmaceutical products" industry.

Titan Pharmaceuticals vs. Its Competitors

Carisma Therapeutics (NASDAQ:CARM) and Titan Pharmaceuticals (NASDAQ:TTNP) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

In the previous week, Carisma Therapeutics and Carisma Therapeutics both had 1 articles in the media. Carisma Therapeutics' average media sentiment score of 1.94 beat Titan Pharmaceuticals' score of 1.87 indicating that Carisma Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Carisma Therapeutics Very Positive
Titan Pharmaceuticals Very Positive

44.3% of Carisma Therapeutics shares are held by institutional investors. Comparatively, 31.5% of Titan Pharmaceuticals shares are held by institutional investors. 6.9% of Carisma Therapeutics shares are held by insiders. Comparatively, 0.7% of Titan Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Carisma Therapeutics presently has a consensus target price of $1.93, indicating a potential upside of 396.13%. Given Carisma Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe Carisma Therapeutics is more favorable than Titan Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Carisma Therapeutics
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71
Titan Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Titan Pharmaceuticals has lower revenue, but higher earnings than Carisma Therapeutics. Titan Pharmaceuticals is trading at a lower price-to-earnings ratio than Carisma Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carisma Therapeutics$19.63M0.83-$60.48M-$1.56-0.25
Titan Pharmaceuticals$180K20.58-$4.71M-$4.59-0.89

Carisma Therapeutics has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, Titan Pharmaceuticals has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500.

Titan Pharmaceuticals has a net margin of 0.00% compared to Carisma Therapeutics' net margin of -254.28%. Carisma Therapeutics' return on equity of 0.00% beat Titan Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Carisma Therapeutics-254.28% N/A -137.38%
Titan Pharmaceuticals N/A -145.92%-129.20%

Summary

Carisma Therapeutics beats Titan Pharmaceuticals on 12 of the 16 factors compared between the two stocks.

Get Titan Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TTNP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TTNP vs. The Competition

MetricTitan PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.69M$3.07B$5.70B$9.51B
Dividend YieldN/A2.36%4.69%4.01%
P/E Ratio-0.8921.0428.0720.05
Price / Sales20.58284.46448.5799.42
Price / CashN/A42.7636.2258.56
Price / Book1.528.378.665.87
Net Income-$4.71M-$55.19M$3.25B$258.55M
7 Day Performance-9.15%5.89%4.20%2.23%
1 Month Performance-6.65%17.63%10.82%12.76%
1 Year Performance-30.31%5.09%34.70%19.36%

Titan Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TTNP
Titan Pharmaceuticals
0.304 of 5 stars
$4.07
-20.7%
N/A-14.2%$4.69M$180K-0.8910Positive News
Gap Up
High Trading Volume
CARM
Carisma Therapeutics
3.1687 of 5 stars
$0.39
-0.6%
$1.93
+393.8%
-63.5%$16.39M$19.63M-0.2520Positive News
CTXR
Citius Pharmaceuticals
3.2695 of 5 stars
$1.44
-5.9%
$53.00
+3,580.6%
-92.7%$16.27MN/A0.0020Positive News
ATHA
Athira Pharma
3.7585 of 5 stars
$0.43
+5.6%
$11.25
+2,510.2%
-86.0%$15.93MN/A-0.2140Positive News
Upcoming Earnings
CASI
CASI Pharmaceuticals
3.9666 of 5 stars
$1.22
-3.2%
$4.00
+227.9%
-78.2%$15.50M$28.54M-0.48180Gap Up
PRPH
ProPhase Labs
0.3854 of 5 stars
$0.40
+10.3%
N/A-86.4%$15.18M$6.77M0.00130Gap Up
ALLR
Allarity Therapeutics
0.7302 of 5 stars
$0.97
-2.3%
N/A-81.0%$15.03MN/A0.0010Positive News
MTEX
Mannatech
1.0455 of 5 stars
$8.08
+2.8%
N/A+11.0%$14.94M$115.04M-80.80250News Coverage
Gap Down
EQ
Equillium
2.9663 of 5 stars
$0.41
-0.2%
$3.00
+624.5%
-58.4%$14.83M$41.10M-1.0640Positive News
Gap Up
ERNA
Ernexa Therapeutics
1.1012 of 5 stars
$1.96
-1.0%
N/A-92.7%$14.58M$580K-0.2410Positive News
Gap Up
PMN
Promis Neurosciences
2.9631 of 5 stars
$1.12
+154.5%
$4.33
+286.9%
-56.9%$14.39MN/A-22.405News Coverage
Analyst Revision
High Trading Volume

Related Companies and Tools


This page (NASDAQ:TTNP) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners